Ken Hawkins, a retired teacher from Grants Pass, is first Oregon participant in phase 3 clinical trial Ken Hawkins, a 77-year ...

During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed quality of life and the future with CAR ...

In a world where fitness enthusiasts are constantly searching for effective supplements to enhance their workouts and accelerate their muscle growth, Revival Point Muscle Genesis emerges as a ...

The rise of antibody therapeutics is transforming drug discovery, providing highly specific treatments for complex diseases ...

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

Cloud Storage Security (CSS), a leader in advanced threat detection and data loss prevention for cloud-native applications, today announced availability of its multi-cloud antimalware solution ...

Here are the most cutting-edge products of the year.

Nutrizoe launches Momix Kheer premix range to offer new mothers: Friday, 15 November, 2024, 08 : 00 AM [IST] Our Bureau, Mumbai: Nutrizoe, India’s leading women’s wellness bra ...

Boosts Metabolism PhenQ helps counter the natural slowdown in metabolism that occurs during menopause, making it easier to ...

WINT Enrolling SCAI Stage C participants in SEISMiC C trial, preparing for Phase 3 readiness Pennsylvania-based Windtree ...

REM stands for rapid eye movement — a stage in the sleep cycle when your brain is almost as active as when you’re awake.

An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.